Zepp Health Reports Strong Q1 2026 Financial Results with 33.8% Revenue Growth
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 48 minutes ago
0mins
Source: PRnewswire
- Significant Revenue Growth: In Q1 2026, Zepp Health reported revenues of $51.5 million, reflecting a 33.8% year-over-year increase, primarily driven by successful new product launches such as Active Max and T-Rex Ultra 2, showcasing the company's robust performance in the consumer electronics market.
- Improved Gross Margin: The gross margin for Q1 stood at 37.7%, up from 37.3% in the same period of 2025, despite pressures from the refresh of lower-margin product lines and rising component costs, indicating ongoing improvements in brand positioning and operational efficiency.
- Increased R&D Investment: Research and development expenses reached $13.1 million in Q1, a 5.6% increase compared to the same period in 2025, reflecting the company's commitment to investing in new product development and technological innovation to maintain competitive advantages and drive future growth.
- Cash Flow and Debt Management: As of March 31, 2026, Zepp Health had cash and cash equivalents totaling $103.2 million, a decrease from the end of 2025, yet the company demonstrated strong debt management by retiring $46.4 million in debt, ensuring financial flexibility and optimizing its capital structure.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ZEPP?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ZEPP
Wall Street analysts forecast ZEPP stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 6.190
Low
64.37
Averages
64.37
High
64.37
Current: 6.190
Low
64.37
Averages
64.37
High
64.37
No data
About ZEPP
Zepp Health Corp, formerly Huami Corp, is a Netherlands-based company primarily engaged in the consumer electronics and digital health technology industry. The Company focuses on developing smart wearable devices and digital health management platforms. Their key product is the Zepp Digital Health Management Platform, which is a cloud-based system integrating smart devices, biometric sensors, Artificial Intelligence (AI) chips, and data algorithms. It aims to provide users with 24/7 actionable insights to support health, fitness, and wellness management. The platform powers a range of products including smartwatches, fitness bands, smart rings, and hearables under the Amazfit and Zepp brand names. Additionally, the Company offers AI-driven services such as Zepp Aura for sound-based wellness and Zepp Clarity for hearing health. The Company has two reportable segments the Xiaomi wearable products segment and Self-branded products and others segment.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Zepp Health Reports Strong Q1 2026 Financial Results with 33.8% Revenue Growth
- Significant Revenue Growth: In Q1 2026, Zepp Health reported revenues of $51.5 million, reflecting a 33.8% year-over-year increase, primarily driven by successful new product launches such as Active Max and T-Rex Ultra 2, showcasing the company's robust performance in the consumer electronics market.
- Improved Gross Margin: The gross margin for Q1 stood at 37.7%, up from 37.3% in the same period of 2025, despite pressures from the refresh of lower-margin product lines and rising component costs, indicating ongoing improvements in brand positioning and operational efficiency.
- Increased R&D Investment: Research and development expenses reached $13.1 million in Q1, a 5.6% increase compared to the same period in 2025, reflecting the company's commitment to investing in new product development and technological innovation to maintain competitive advantages and drive future growth.
- Cash Flow and Debt Management: As of March 31, 2026, Zepp Health had cash and cash equivalents totaling $103.2 million, a decrease from the end of 2025, yet the company demonstrated strong debt management by retiring $46.4 million in debt, ensuring financial flexibility and optimizing its capital structure.
See More
Zepp Health Reports Q1 2026 Financial Highlights with 33.8% Revenue Growth
- Significant Revenue Growth: In Q1 2026, Zepp Health reported revenues of $51.5 million, marking a 33.8% year-over-year increase that aligns with company guidance, demonstrating strong market response to new product launches and reinforcing its position in the smart wearable market.
- Slight Margin Improvement: The gross margin for Q1 was 37.7%, up 0.4 percentage points from the same period in 2025, despite pressures from rising memory component costs, indicating effective product mix optimization and cost control measures.
- Strong Cash Flow Management: As of March 31, 2026, the company held $103.2 million in cash and cash equivalents, nearly flat compared to the previous year, showcasing financial stability and effective cash flow management during the traditionally low season.
- Optimistic Future Outlook: The company anticipates Q2 2026 revenues between $63.0 million and $68.0 million, representing a year-over-year increase of approximately 6% to 14%, reflecting confidence in sustained demand across its product portfolio and market expansion.
See More
Amazfit Launches New Balance Series Smartwatches
- Product Launch: Amazfit unveils the Balance 3 and Balance Ultra smartwatches, integrating advanced hardware with Zepp App intelligence to assist athletes in structured training across strength, endurance, and recovery, thereby enhancing training effectiveness and quality of life.
- Battery Life Advantage: The Balance 3 offers up to 21 days of battery life, while the Balance Ultra extends this to 30 days, ensuring users do not need to frequently recharge during intense training and daily use, thus improving user experience and satisfaction.
- HYROX Training Support: As the official wearable partner of HYROX, the Balance series provides specialized training plans and race simulations, helping athletes prepare more intentionally for training and competition, thereby enhancing overall performance.
- Health Monitoring Features: Both watches support 25 auto-recognized strength exercises and include metrics for heart rate, HRV, sleep, and blood oxygen, enabling users to gain a comprehensive understanding of their physical condition to optimize training and recovery strategies.
See More
Zepp Health to Report Q1 2026 Earnings on June 8
- Earnings Report Schedule: Zepp Health is set to announce its first quarter 2026 unaudited financial results on June 8, 2026, highlighting the company's ongoing growth potential in the smart wearables and health technology sectors.
- Conference Call Timing: Management will hold a conference call at 9:30 p.m. ET on June 8, expected to attract significant attention from investors and analysts, thereby enhancing the company's transparency.
- Global User Base: To date, Zepp has shipped over 200 million devices to more than 53 million users worldwide, demonstrating its strong influence and market penetration in the smart health sector.
- Technological Platform Advantage: Leveraging its proprietary Zepp Digital Management Platform, Zepp Health provides 24/7 actionable insights and guidance to help users achieve their health goals, further solidifying its market leadership.
See More
Zepp Health to Report Q1 2026 Earnings on June 8
- Earnings Announcement: Zepp Health is set to report its unaudited financial results for Q1 2026 on June 8, 2026, reflecting the company's ongoing growth in the smart wearables and health technology sectors.
- Conference Call Schedule: Management will hold a conference call at 9:30 p.m. ET on June 8, allowing investors to dial in and stay updated on the latest company developments.
- Global User Base: To date, Zepp has shipped over 200 million units to more than 53 million users across over 150 countries, showcasing its significant impact in the smart health market.
- Technological Platform Advantage: Leveraging its proprietary Zepp Digital Management Platform, which integrates AI chips and biometric sensors, Zepp Health provides 24/7 actionable health insights and guidance, further solidifying its market leadership.
See More
Zepp Health (ZEPP) Q4 2025 Earnings Transcript
See More
Zepp Health Reports Strong Q1 2026 Financial Results with 33.8% Revenue Growth
- Significant Revenue Growth: In Q1 2026, Zepp Health reported revenues of $51.5 million, reflecting a 33.8% year-over-year increase, primarily driven by successful new product launches such as Active Max and T-Rex Ultra 2, showcasing the company's robust performance in the consumer electronics market.
- Improved Gross Margin: The gross margin for Q1 stood at 37.7%, up from 37.3% in the same period of 2025, despite pressures from the refresh of lower-margin product lines and rising component costs, indicating ongoing improvements in brand positioning and operational efficiency.
- Increased R&D Investment: Research and development expenses reached $13.1 million in Q1, a 5.6% increase compared to the same period in 2025, reflecting the company's commitment to investing in new product development and technological innovation to maintain competitive advantages and drive future growth.
- Cash Flow and Debt Management: As of March 31, 2026, Zepp Health had cash and cash equivalents totaling $103.2 million, a decrease from the end of 2025, yet the company demonstrated strong debt management by retiring $46.4 million in debt, ensuring financial flexibility and optimizing its capital structure.
See More
Zepp Health Reports Q1 2026 Financial Highlights with 33.8% Revenue Growth
- Significant Revenue Growth: In Q1 2026, Zepp Health reported revenues of $51.5 million, marking a 33.8% year-over-year increase that aligns with company guidance, demonstrating strong market response to new product launches and reinforcing its position in the smart wearable market.
- Slight Margin Improvement: The gross margin for Q1 was 37.7%, up 0.4 percentage points from the same period in 2025, despite pressures from rising memory component costs, indicating effective product mix optimization and cost control measures.
- Strong Cash Flow Management: As of March 31, 2026, the company held $103.2 million in cash and cash equivalents, nearly flat compared to the previous year, showcasing financial stability and effective cash flow management during the traditionally low season.
- Optimistic Future Outlook: The company anticipates Q2 2026 revenues between $63.0 million and $68.0 million, representing a year-over-year increase of approximately 6% to 14%, reflecting confidence in sustained demand across its product portfolio and market expansion.
See More
Amazfit Launches New Balance Series Smartwatches
- Product Launch: Amazfit unveils the Balance 3 and Balance Ultra smartwatches, integrating advanced hardware with Zepp App intelligence to assist athletes in structured training across strength, endurance, and recovery, thereby enhancing training effectiveness and quality of life.
- Battery Life Advantage: The Balance 3 offers up to 21 days of battery life, while the Balance Ultra extends this to 30 days, ensuring users do not need to frequently recharge during intense training and daily use, thus improving user experience and satisfaction.
- HYROX Training Support: As the official wearable partner of HYROX, the Balance series provides specialized training plans and race simulations, helping athletes prepare more intentionally for training and competition, thereby enhancing overall performance.
- Health Monitoring Features: Both watches support 25 auto-recognized strength exercises and include metrics for heart rate, HRV, sleep, and blood oxygen, enabling users to gain a comprehensive understanding of their physical condition to optimize training and recovery strategies.
See More
Zepp Health to Report Q1 2026 Earnings on June 8
- Earnings Report Schedule: Zepp Health is set to announce its first quarter 2026 unaudited financial results on June 8, 2026, highlighting the company's ongoing growth potential in the smart wearables and health technology sectors.
- Conference Call Timing: Management will hold a conference call at 9:30 p.m. ET on June 8, expected to attract significant attention from investors and analysts, thereby enhancing the company's transparency.
- Global User Base: To date, Zepp has shipped over 200 million devices to more than 53 million users worldwide, demonstrating its strong influence and market penetration in the smart health sector.
- Technological Platform Advantage: Leveraging its proprietary Zepp Digital Management Platform, Zepp Health provides 24/7 actionable insights and guidance to help users achieve their health goals, further solidifying its market leadership.
See More
Zepp Health to Report Q1 2026 Earnings on June 8
- Earnings Announcement: Zepp Health is set to report its unaudited financial results for Q1 2026 on June 8, 2026, reflecting the company's ongoing growth in the smart wearables and health technology sectors.
- Conference Call Schedule: Management will hold a conference call at 9:30 p.m. ET on June 8, allowing investors to dial in and stay updated on the latest company developments.
- Global User Base: To date, Zepp has shipped over 200 million units to more than 53 million users across over 150 countries, showcasing its significant impact in the smart health market.
- Technological Platform Advantage: Leveraging its proprietary Zepp Digital Management Platform, which integrates AI chips and biometric sensors, Zepp Health provides 24/7 actionable health insights and guidance, further solidifying its market leadership.
See More
Zepp Health (ZEPP) Q4 2025 Earnings Transcript
See More
